home / stock / gikly / gikly news


GIKLY News and Press, Grifols SA Barcelona ADR

Stock Information

Company Name: Grifols SA Barcelona ADR
Stock Symbol: GIKLY
Market: OTC
Website: grifols.com

Menu

GIKLY GIKLY Quote GIKLY Short GIKLY News GIKLY Articles GIKLY Message Board
Get GIKLY Alerts

News, Short Squeeze, Breakout and More Instantly...

GIKLY - Showcasing Seeking Alpha's May 2024 New Analysts

2024-06-07 12:00:00 ET Summary In May, we had another twenty-four new analysts join us with their first idea on the site. Some companies covered in this edition: Target, JAKKS Pacific, Li Auto, Qudian, Pfizer, Dexcom, UnitedHealth Group, Verano, and more! Take a look for new a...

GIKLY - Harris Associates International Small Cap Strategy Q1 2024 Commentary

2024-05-25 09:05:00 ET Summary Harris Associates is an asset management firm that serves as the investment adviser to the Oakmark Funds. We seek to invest in businesses that are priced at substantial discounts to our estimate of intrinsic value. Major global equity markets showed ...

GIKLY - Grifols: Q4 Was Positive, Still Too Many Question Marks

2024-03-05 10:19:08 ET Summary Grifols faces new accusations from the hedge fund Gotham City. Gotham City questions loans and outgoing flows recorded in Grifols' financial report, as well as the role of Scranton Enterprises. Grifols disclosed a lack of FCF generation in 2024. ...

GIKLY - Grifols appoints new CEO; founding family members to leave executive roles

2024-02-05 14:20:46 ET More on Grifols Grifols: Wait And See For Now Grifols: I've Read The Short-Seller Report, And I Mostly Disagree Grifols Is Building Momentum Grifols’ banking exposure under ECB scrutiny: Reuters ELAB, KIND and RLX among p...

GIKLY - Grifols Investor Reminder

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Grifols To Contact Him Directly To Discuss Their Options If you suffered significant losses in Grifols stock or options and would like to discuss your legal rights, call Faruqi & Faruq...

GIKLY - Grifols' banking exposure under ECB scrutiny: Reuters

2024-01-17 14:56:12 ET More on Grifols S.A. Grifols: Wait And See For Now Grifols: I've Read The Short-Seller Report, And I Mostly Disagree Grifols Is Building Momentum ELAB, KIND and RLX among pre-market losers Haier Group still looking to buy Shangh...

GIKLY - Grifols Shareholder Action Reminder

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Grifols To Contact Him Directly To Discuss Their Options If you suffered significant losses in Grifols stock or options and would like to discuss your legal rights, call Faruqi & Faruq...

GIKLY - Grifols: Wait And See For Now

2024-01-10 13:15:00 ET Summary Gotham City's recent allegations against Grifols have caused GFRS stock to significantly decline. Our team at Mare will remain waiting for clarifications. We expect the company's stock to be under pressure in the short term and probably not investabl...

GIKLY - Grifols shares plunge after report on debt ratio concerns

2024-01-09 06:46:54 ET More on Grifols S.A. Grifols Is Building Momentum Grifols, S.A. (GRFS) Q3 2023 Earnings Call Transcript Grifols gains on plans to sell 20% of Shanghai RAAS stake to Haier Grifols said to be in talks for a partial sale of Shanghai RAAS ...

GIKLY - Doubling Down On Gain Therapeutics

2023-12-22 17:56:28 ET Summary The biotech bear market has presented investment opportunities for investors to take meaningful stakes in public companies at venture valuations. AI drug discovery has faced setbacks in the past 18 months, but Gain Therapeutics' has found success usi...

Next 10